AAO-HNS GUIDELINES Bundle (free trial)

Sudden Hearing Loss

American Academy of Otolaryngology-Head and Neck Surgery Foundation GUIDELINES Apps brought to you free pf charge, courtesy of Guideline Central. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/327549

Contents of this Issue

Navigation

Page 4 of 17

5 Table 2. Summary of Key Action Statements (KAS) Statement Action Grade 10. Intratympanic steroids for salvage therapy Clinicians should offer, or refer to a clinician who can offer, intratympanic (IT) steroid therapy when patients have incomplete recovery from SSNHL 2–6 weeks aer onset of symptoms. Recommendation 11. Other pharmacologic therapy Clinicians should NOT routinely prescribe antivirals, thrombolytics, vasodilators, or vasoactive substances to patients with SSNHL. Strong recommendation against 12. Outcomes Assessment Clinicians should obtain follow-up audiometric evaluation for patients with SSNHL at the conclusion of treatment and within six months of completion of treatment. Recommendation 13. Rehabilitation Clinicians should counsel patients with SSNHL who have residual hearing loss and/or tinnitus about the possible benefits of audiological rehabilitation and other supportive measures. Strong recommendation (cont'd)

Articles in this issue

Archives of this issue

view archives of AAO-HNS GUIDELINES Bundle (free trial) - Sudden Hearing Loss